F Creekmore. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Acute DiseaseAngina, Unstable/drug therapyAnticoagulants/administration & dosageAnticoagulants/therapeutic useAspirin/therapeutic useDalteparin/administration & dosageDalteparin/therapeutic useDouble-Blind MethodEnoxaparin/administration & dosageEnoxaparin/therapeutic useFibrinolytic Agents/administration & dosageFibrinolytic Agents/therapeutic useHeparin, Low-Molecular-Weight/administration & dosageHeparin, Low-Molecular-Weight/therapeutic useHumansPlacebosPlatelet Aggregation Inhibitors/therapeutic useRandomized Controlled Trials as TopicTime Factors
Substances： See more » AnticoagulantsEnoxaparinFibrinolytic AgentsHeparin, Low-Molecular-WeightPlacebosPlatelet Aggregation InhibitorsAspirinDalteparin
Year: 2000 PMID： 10652862
Source DB: PubMed Journal: S D J Med